Ates, O. Et Al. 2021. Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data. Journal of B.U.ON. , vol.26, no.4 , 1398-1404.

Ates, O., Oksuzoglu, O. B., AKTAŞ, B. Y., Karadag, I., Esen, S., Karakaya, S., ... Uncu, D.(2021). Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data. Journal of B.U.ON. , vol.26, no.4, 1398-1404.

Ates, Ozturk Et Al. "Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data," Journal of B.U.ON. , vol.26, no.4, 1398-1404, 2021

Ates, Ozturk Et Al. "Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data." Journal of B.U.ON. , vol.26, no.4, pp.1398-1404, 2021

Ates, O. Et Al. (2021) . "Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data." Journal of B.U.ON. , vol.26, no.4, pp.1398-1404.

@article{article, author={Ozturk Ates Et Al. }, title={Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data}, journal={Journal of B.U.ON.}, year=2021, pages={1398-1404} }